The fair value of requested stock should be $99.54
* Note: Prices are in Million (M) USD.
These criteria used Company’s Cash, EBITDA and Debt balance to determines its fair value:
Cash : $559 M
Debt : $3,820 M
EBITDA : $743 M
Net Debt (Debt - Cash): $3,261 M
Since EBITDA cannot cover net debt within 3 years, Avoid This Stock.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Based on industry, 3 points assigned.
This criteria used Company’s Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 8.08
Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $356 M
Average Revenue: $3,679 M
Free Cash Flow to Revenue : 10 %
Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $4,373 M
Revenue 4 Years Ago (2020-12-31): $5,063 M
Revenue Growth: -3%
Since Revenue Growth is between 0 - 5, 1 point assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $137 M
Share Count 5 Years Ago (2020-12-31): $136 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Earnings Per Share (EPS): $3.12
Dividend Per Share (DPS): $1
Payout Ratio: 35%
Dividend Yield: 5%
Since company Payout Ratio is less than 50, 2 points assigned.
Since Dividend Yield is greater than 4, 4 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: 3%
Since Average ROE is less than 10, 1 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $25
52-Week Low: $23
Threshold Price (15% Above 52-Week Low): $26
Since Current price is within 15% threshold, 5 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $3,396 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 2% exposure of Total Portfolio.
Value-Trade has assigned 23 points to above Perrigo Company PLC (PRGO) stock.
Value-Trades has assined P/E value 15. Since current year earning per share is $3.12.
The fair value of Perrigo Company PLC (PRGO) stock should be (15 x $3.12) = $46.80
Join Discussion Group